These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21895016)

  • 21. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
    Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
    Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
    J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.
    Sakkiah S; Chandrasekaran M; Lee Y; Kim S; Lee KW
    J Biomol Struct Dyn; 2012; 30(3):235-54. PubMed ID: 22694102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
    Huang S; Song C; Wang X; Zhang G; Wang Y; Jiang X; Sun Q; Huang L; Xiang R; Hu Y; Li L; Yang S
    J Chem Inf Model; 2017 Apr; 57(4):669-679. PubMed ID: 28301150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Evaluation of Novel Benzofuran Derivatives as Selective SIRT2 Inhibitors.
    Zhou Y; Cui H; Yu X; Peng T; Wang G; Wen X; Sun Y; Liu S; Zhang S; Hu L; Wang L
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28805748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies.
    Chowdhury S; Sripathy S; Webster A; Park A; Lao U; Hsu JH; Loe T; Bedalov A; Simon JA
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors.
    Zheng YC; Wang LZ; Zhao LJ; Zhao LJ; Zhan QN; Ma JL; Zhang B; Wang MM; Wang ZR; Li JF; Liu Y; Chen ZS; Shen DD; Liu XQ; Ren M; Lv WL; Zhao W; Duan YC; Liu HM
    Cell Physiol Biochem; 2016; 38(1):185-93. PubMed ID: 26784898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
    Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
    Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of Sirt3 complexes with 4'-bromo-resveratrol reveal binding sites and inhibition mechanism.
    Nguyen GT; Gertz M; Steegborn C
    Chem Biol; 2013 Nov; 20(11):1375-85. PubMed ID: 24211137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
    Tervo AJ; Kyrylenko S; Niskanen P; Salminen A; Leppänen J; Nyrönen TH; Järvinen T; Poso A
    J Med Chem; 2004 Dec; 47(25):6292-8. PubMed ID: 15566299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for potent inhibition of SIRT2 deacetylase by a macrocyclic peptide inducing dynamic structural change.
    Yamagata K; Goto Y; Nishimasu H; Morimoto J; Ishitani R; Dohmae N; Takeda N; Nagai R; Komuro I; Suga H; Nureki O
    Structure; 2014 Feb; 22(2):345-52. PubMed ID: 24389023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
    Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
    Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative insights for the design of substrate-based SIRT1 inhibitors.
    Kokkonen P; Mellini P; Nyrhilä O; Rahnasto-Rilla M; Suuronen T; Kiviranta P; Huhtiniemi T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2014 Aug; 59():12-9. PubMed ID: 24747578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.
    Manjulatha K; Srinivas S; Mulakayala N; Rambabu D; Prabhakar M; Arunasree KM; Alvala M; Basaveswara Rao MV; Pal M
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6160-5. PubMed ID: 22929231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.
    Kiviranta PH; Leppänen J; Rinne VM; Suuronen T; Kyrylenko O; Kyrylenko S; Kuusisto E; Tervo AJ; Järvinen T; Salminen A; Poso A; Wallén EA
    Bioorg Med Chem Lett; 2007 May; 17(9):2448-51. PubMed ID: 17329104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins.
    Botta G; De Santis LP; Saladino R
    Curr Med Chem; 2012; 19(34):5871-84. PubMed ID: 22998567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
    Kiviranta PH; Salo HS; Leppänen J; Rinne VM; Kyrylenko S; Kuusisto E; Suuronen T; Salminen A; Poso A; Lahtela-Kakkonen M; Wallén EA
    Bioorg Med Chem; 2008 Sep; 16(17):8054-62. PubMed ID: 18701307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
    Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.